Crestwood Advisors Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.68M Buy
19,375
+7,773
+67% +$745K 0.03% 243
2025
Q4
$1.11M Buy
11,602
+2,802
+32% +$272K 0.02% 267
2025
Q3
$838K Buy
8,800
+2,140
+32% +$197K 0.01% 304
2025
Q2
$581K Sell
6,660
-275
-4% -$23.3K 0.01% 328
2025
Q1
$623K Buy
6,935
+411
+6% +$36.8K 0.01% 318
2024
Q4
$521K Sell
6,524
-565
-8% -$48.9K 0.01% 300
2024
Q3
$638K Buy
7,089
+525
+8% +$44.2K 0.01% 267
2024
Q2
$517K Sell
6,564
-648
-9% -$53.1K 0.01% 275
2024
Q1
$629K Buy
7,212
+1,691
+31% +$144K 0.01% 252
2023
Q4
$455K Buy
5,521
+623
+13% +$47.5K 0.01% 269
2023
Q3
$384K Buy
4,898
+2,067
+73% +$173K 0.01% 269
2023
Q2
$249K Buy
2,831
+252
+10% +$21.7K 0.01% 226
2023
Q1
$208K Sell
2,579
-45
-2% -$3.67K 0.01% 248
2022
Q4
$204K Buy
2,624
+86
+3% +$6.97K 0.01% 251
2022
Q3
$205K Sell
2,538
-2,257
-47% -$203K 0.01% 249
2022
Q2
$430K Buy
4,795
+309
+7% +$31.3K 0.01% 200
2022
Q1
$498K Sell
4,486
-111,927
-96% -$11.8M 0.01% 200
2021
Q4
$12M Sell
116,413
-241,065
-67% -$27.9M 0.31% 70
2021
Q3
$44.8M Buy
357,478
+465
+0.1% +$60.2K 1.27% 27
2021
Q2
$44.3M Buy
357,013
+8,133
+2% +$1.02M 1.28% 25
2021
Q1
$41.2M Buy
348,880
+13,223
+4% +$1.55M 1.3% 24
2020
Q4
$39.3M Buy
335,657
+26,765
+9% +$2.95M 1.3% 24
2020
Q3
$32.1M Buy
308,892
+544
+0.2% +$54.6K 1.21% 30
2020
Q2
$28.3M Buy
308,348
+10,613
+4% +$1.02M 1.13% 33
2020
Q1
$26.9M Buy
297,735
+17,069
+6% +$1.82M 1.33% 24
2019
Q4
$31.8M Buy
280,666
+6,407
+2% +$703K 1.26% 26
2019
Q3
$29.8M Buy
274,259
+5,253
+2% +$548K 1.31% 26
2019
Q2
$26.2M Buy
269,006
+6,746
+3% +$616K 1.19% 31
2019
Q1
$23.9M Buy
262,260
+7,199
+3% +$644K 1.71% 20
2018
Q4
$23.2M Buy
255,061
+2,857
+1% +$267K 1.85% 18
2018
Q3
$24.8M Sell
252,204
-2,343
-0.9% -$217K 1.74% 18
2018
Q2
$23.1M Sell
254,547
-1,214
-0.5% -$101K 1.68% 19
2018
Q1
$20.5M Buy
255,761
+9,210
+4% +$760K 1.61% 22
2017
Q4
$19.9M Sell
246,551
-5,444
-2% -$436K 1.58% 22
2017
Q3
$19.6M Buy
251,995
+4,275
+2% +$355K 1.68% 21
2017
Q2
$20.9M Sell
247,720
-4,041
-2% -$341K 1.78% 20
2017
Q1
$21.3M Buy
251,761
+22,297
+10% +$1.74M 1.88% 15
2016
Q4
$16.3M Sell
229,464
-15,412
-6% -$1.21M 1.58% 26
2016
Q3
$21.2M Buy
244,876
+7,473
+3% +$651K 2.53% 10
2016
Q2
$20.6M Buy
237,403
+1,907
+0.8% +$154K 2.55% 12
2016
Q1
$17.7M Buy
235,496
+10,899
+5% +$821K 2.08% 18
2015
Q4
$17.3M Buy
224,597
+5,704
+3% +$429K 2.08% 15
2015
Q3
$14.7M Buy
218,893
+11,440
+6% +$843K 1.9% 24
2015
Q2
$15.4M Buy
207,453
+20,260
+11% +$1.55M 2.05% 17
2015
Q1
$14.6M Buy
187,193
+55,025
+42% +$4.17M 2.08% 19
2014
Q4
$9.54M Buy
132,168
+126,749
+2,339% +$8.8M 1.44% 38
2014
Q3
$336K Sell
5,419
-247
-4% -$15.7K 0.05% 89
2014
Q2
$361K Sell
5,666
-157
-3% -$9.54K 0.06% 86
2014
Q1
$358K Sell
5,823
-1,254
-18% -$73K 0.06% 88
2013
Q4
$406K Sell
7,077
-179
-2% -$10.2K 0.06% 83
2013
Q3
$386K Hold
7,256
0.07% 83
2013
Q2
$373K Buy
+7,256
New +$359K 0.07% 88

Other funds holding MDT

Crestwood Advisors Group's MDT Position: Q1 2026 in Review

Crestwood Advisors Group increased its Medtronic (MDT) stake by 67% in Q1 2026, buying an estimated $745K and bringing the position to 19,375 shares worth $1.68M. The position accounts for 0.03% of the portfolio, ranked #243.

Crestwood Advisors Group first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $44.8M in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Crestwood Advisors Group held 19,375 shares of Medtronic worth $1.68M as of Q1 2026.
  • Crestwood Advisors Group bought 7,773 Medtronic shares in Q1 2026, an estimated $745K.
  • Medtronic made up 0.03% of Crestwood Advisors Group's portfolio in Q1 2026, its #243 holding.
  • Crestwood Advisors Group first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Crestwood Advisors Group's Medtronic position peaked at $44.8M in Q3 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Crestwood Advisors Group's 13F filing for Q1 2026, filed 5 May 2026.